Best Sellers
Methylene blue solution
£34.99Methylene Blue
- 1% concentration — 10 mg/mL
- High-purity methylene blue solution
- Long-established research compound with applications in chemistry, biology and medicine.
- Redox-active compound capable of participating in oxidation-reduction reactions.
- Mitochondrial research interest — methylene blue has been studied experimentally in connection with mitochondrial electron transport and cellular energy metabolism.
- Neuroscience research interest — experimental research has examined potential effects on memory, cognition and neurological processes, but these are not established health benefits.
- Oxidative-stress research — its redox properties have prompted research into its interaction with cellular oxidative processes.
- Laboratory/research applications — historically used extensively as a biological stain and research reagent.
MGF
£19.99mgMGF
Performance & Muscle Growth — IGF-1 Splice Variant Mechano Growth Factor MGF (Mechano Growth Factor) is a splice variant of IGF-1 (IGF-1Ec) produced locally in skeletal muscle in response to mechanical stress or damage. Research focuses on its role in satellite cell activation, the first stage of the muscle repair and growth process. Mechanism: IGF-1Ec splice variant — E-peptide-mediated satellite cell activation Primary Research: Muscle repair & satellite cell activation Related Compound: PEG-MGF (extended half-life analogue)
NAD+ (Capsules)
Price range: £48.99 through £68.99mg
NAD+ (Pen)
Price range: £48.99 through £68.99mg
NAD+ (Vial)
Price range: £23.99 through £38.99mg
Retatrutide (Pen)
Price range: £49.99 through £113.99Retatrutide
Metabolics & GLP-1 — Triple Agonist
GIP/GLP-1/GCG triple agonist peptide
Retatrutide is an investigational once-weekly triple agonist of the GIP, GLP-1, and glucagon receptors (triple G). In the Phase II SURMOUNT dose-finding trial, 12 mg weekly produced mean body weight loss of 24.2% at 48 weeks — the highest reported for any pharmacological agent in a controlled trial.
Mechanism:
GIP + GLP-1 + glucagon triple agonist
Stage:
Phase III trials (as of 2026)
Peak Phase II Weight Loss:
24.2% at 48 weeks
Retatrutide (Vial)
Price range: £58.99 through £92.99Retatrutide
Metabolics & GLP-1 — Triple Agonist
GIP/GLP-1/GCG triple agonist peptide
Retatrutide is an investigational once-weekly triple agonist of the GIP, GLP-1, and glucagon receptors (triple G). In the Phase II SURMOUNT dose-finding trial, 12 mg weekly produced mean body weight loss of 24.2% at 48 weeks — the highest reported for any pharmacological agent in a controlled trial.
Mechanism:
GIP + GLP-1 + glucagon triple agonist
Stage:
Phase III trials (as of 2026)
Peak Phase II Weight Loss:
24.2% at 48 weeks
Selank
Price range: £33.99 through £41.99mgSelank
Neuropeptide — CNS & Mood Tuftsin-analogue anxiolytic peptide Selank is a synthetic heptapeptide analogue of tuftsin developed at the Institute of Molecular Genetics, Moscow. Studied as an anxiolytic, nootropic, and immunomodulator with a favourable safety profile and no observed dependence in animal studies — distinguishing it from classical benzodiazepines. Origin: Tuftsin analogue Developer: IMGenetika, Moscow Status: Approved Russia/Ukraine
SLU-PP-332
£79.99SLU-PP-332
Metabolic — Exercise Mimetic / ERR Agonist
Synthetic ERRα/β/γ pan-agonist · small molecule
SLU-PP-332 is a first-in-class synthetic pan-agonist of the oestrogen-related receptor (ERR) family — ERRα, ERRβ, and ERRγ. Developed at Saint Louis University, it activates the same nuclear receptor transcription factors as aerobic exercise, producing measurable improvements in endurance, fat oxidation, and metabolic health in preclinical models without physical activity. It represents one of the most promising “exercise mimetic” compounds in current research.
Class
ERRα/β/γ pan-agonist — small molecule
Developer
Saint Louis University (Bhatt lab)
Stage
Preclinical — 2023/24 landmark studies
TB-500
Price range: £17.99 through £71.99mgTB-500
Bioregulator — Thymosin β4 Fragment Actin-sequestering regenerative peptide TB-500 is a synthetic fragment of thymosin beta-4, retaining the key G-actin-sequestering domain responsible for its regenerative properties. Studied particularly for cardiac, skeletal muscle, ocular, and tendon repair. Source Protein: Thymosin β4 (Tβ4) Key Mechanism: Actin sequestration Molecular Weight: ~860 Da (fragment)
Tirzepatide (Pen)
Price range: £54.99 through £74.99Tirzepatide
Metabolics & GLP-1 — GIP + GLP-1 Dual Agonist
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and obesity. Clinical trials demonstrate superior weight loss compared to semaglutide, with up to 22.5% mean body weight reduction at 15 mg weekly dosing.
Tirzepatide (Vial)
Price range: £34.99 through £54.99Tirzepatide
Metabolics & GLP-1 — GIP + GLP-1 Dual Agonist
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and obesity. Clinical trials demonstrate superior weight loss compared to semaglutide, with up to 22.5% mean body weight reduction at 15 mg weekly dosing.
